iRhythm Technologies

IRTCleader

iRhythm's Zio Patch is the dominant long-term ambulatory cardiac monitor, using AI to analyze 100M+ hours of ECG data and detect atrial fibrillation that short-duration Holter monitors miss.

⇄ Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($601M)

Datos estáticos (cargando finanzas en tiempo real…)

US Revenue (88%)

International (12%)

Composición de segmentos y clientes principales

Detalles del producto

Zio Patch (Long-term ECG)92%

Wear-once 14-day continuous ECG patch worn on the chest, with AI-powered arrythmia detection — 100M+ days of data.

Zio Monitor (Short-term)8%

3-day wireless patch for acute symptom monitoring, compatible with existing prescribing workflows.

Relaciones en la Cadena de Suministro

Clientes Clave

UnitedHealth Group

Insurance coverage for Zio Patch

Impacto: significant

HCA Healthcare

Hospital Zio adoption

Impacto: significant

Contexto macro y de mercado

헬스케어Noticias del sector

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Próximos catalizadores

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de iRhythm Technologies impulsado por IA.

Información de la Empresa

Sede Central

San Francisco, California, USA

Fundación

2006

Empleados

1,900

Sitio Web

irhythmtech.com

Estado del sector — 헬스케어

Noticias del sector